Independent Labs, Institutes, and Centers (Dean of Research)
Showing 21-40 of 164 Results
-
Niyatee Samudra, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Samudra is a clinical assistant professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine. She specializes in the care of patients with memory disorders and epilepsy. She has completed fellowship training in behavioral neurology at the University of California, San Francisco, as well as in epilepsy and clinical neurophysiology at Vanderbilt University Medical Center. Dr. Samudra is board-certified in neurology and in epilepsy.
Her research interests include clinical trials in memory disorders and epilepsy; early neurophysiological markers of Alzheimer’s disease and related disorders; neuropsychiatric symptoms in neurodegenerative disorders; and the cognitive and neuropsychiatric consequences of epilepsy. She is interested in improving neurologic care for underserved populations.
Dr. Samudra has published in the Journal of Alzheimer’s Disease; Current Neurology and Neuroscience Reports; Journal of the Neurological Sciences; Seizure; and Epilepsy and Behavior, among others. She is a member of the American Academy of Neurology. -
Peter L. Santa Maria, MBBS, PhD
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Bioengineering
On Partial Leave from 08/01/2023 To 07/14/2024Current Research and Scholarly InterestsWe study chronic suppurative otitis media, a chronic biofilm infection of the middle ear predominantly involving pseudomonas and staph aureus. We are investigating mechanisms of sensory hearing loss, host microbe interactions and trialling novel therapeutics.
Our work in tympanic membrane regeneration has entered clinical trials.
Novel treatments for wound healing in intra oral wounds with potential applications to prevent post tonsillectomy wound healing and oral mucositis. -
Juan G. Santiago
Charles Lee Powell Foundation Professor
Current Research and Scholarly Interestshttp://microfluidics.stanford.edu/Projects/Projects.html
-
Serena Sanulli
Assistant Professor of Genetics
Current Research and Scholarly InterestsWe study the organizing principles of the genome and how these principles regulate cell identity and developmental switches. We combine Biochemistry and Biophysical methods such as NMR and Hydrogen-Deuterium Exchange-MS with Cell Biology, and Genetics to explore genome organization across length and time scales and understand how cells leverage the diverse biophysical properties of chromatin to regulate genome function.
-
Robert Sapolsky
John A. and Cynthia Fry Gunn Professor, Professor of Biology, of Neurology and of Neurosurgery
Current Research and Scholarly InterestsNeuron death, stress, gene therapy
-
Kavita Sarin, MD, PhD
Associate Professor of Dermatology
Current Research and Scholarly InterestsMy research encompasses two main areas: 1) Using next-generation RNA, whole genome, and exome sequencing, we are investigating the genetic alterations involved in skin cancer progression, response to therapy, and other clinical outcomes and 2) We are developing and implementing genome-wide genetic risk prediction assessments for skin cancer into clinical use and studying the impact of this information on patient care.
-
Peter Sarnow
Burt and Marion Avery Professor of Immunology
Current Research and Scholarly InterestsOur laboratory studies virus-host interactions with an emphasis microRNA-mediated gene regulation and on translational control. The mechanism by which a liver-specific microRNA regulates hepatitis C virus genome replication is under intense scrutiny. In addition, the mechanism of internal ribosome entry in certain cellular and viral mRNAs and its biological role in growth and development is being investigated.
-
Ansuman Satpathy
Associate Professor of Pathology
Current Research and Scholarly InterestsOur lab works at the interface of immunology, cancer biology, and genomics to study cellular and molecular mechanisms of the immune response to cancer. In particular, we are leveraging high-throughput genomic technologies to understand the dynamics of the tumor-specific T cell response to cancer antigens and immunotherapies (checkpoint blockade, CAR-T cells, and others). We are also interested in understanding the impact of immuno-editing on the heterogeneity and clonal evolution of cancer.
-
Elizabeth Sattely
Associate Professor of Chemical Engineering
BioPlants have an extraordinary capacity to harvest atmospheric CO2 and sunlight for the production of energy-rich biopolymers, clinically used drugs, and other biologically active small molecules. The metabolic pathways that produce these compounds are key to developing sustainable biofuel feedstocks, protecting crops from pathogens, and discovering new natural-product based therapeutics for human disease. These applications motivate us to find new ways to elucidate and engineer plant metabolism. We use a multidisciplinary approach combining chemistry, enzymology, genetics, and metabolomics to tackle problems that include new methods for delignification of lignocellulosic biomass and the engineering of plant antibiotic biosynthesis.
-
Alan F. Schatzberg
Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsBiological bases of depressive disorders;, glucocorticoid/dopamine interactions in delusional depression;, pharmacologic treatment of depressive disorders.
-
Londa Schiebinger
John L. Hinds Professor of the History of Science
BioLonda Schiebinger is the John L. Hinds Professor of History of Science in the History Department at Stanford University and Director of the EU/US Gendered Innovations in Science, Health & Medicine, Engineering, and Environment Project. From 2004-2010, Schiebinger served as the Director of Stanford's Clayman Institute for Gender Research. She is a member of the American Academy of Arts and Sciences.
Professor Schiebinger received her Ph.D. from Harvard University in 1984 and is a leading international authority on gender in science and technology. Over the past thirty years, Schiebinger's work has been devoted to teasing apart three analytically distinct but interlocking pieces of the gender and science puzzle: the history of women's participation in science; gender in the structure of scientific institutions; and the gendering of human knowledge.
Londa Schiebinger presented the keynote address and wrote the conceptual background paper for the United Nations' Expert Group Meeting on Gender, Science, and Technology, September 2010 in Paris. She presented the findings at the United Nations in New York, February 2011 with an update spring 2014. In 2022, she prepared the background paper for the United Nations 67th session of the Commission on the Status of Women’s priority theme, Innovation and Technological Change, and Education in the Digital Age for Achieving Gender Equality and The Empowerment of all Women and Girls. Since 2023, Gendered Innovations has been a member of the UNFPA Equity 2030 Alliance.
In 2011-2014, Schiebinger entered into major collaborations with the European Commission and the U.S. National Science Foundation to promote Gendered Innovations in Science, Health & Medicine, Engineering, and Environment. This project draws experts from across the U.S., Europe, Canada, and Asia, and was presented at the European Parliament, July 2013 as Gendered Innovations: How Gender Analysis Contributes to Research. In 2018-2020, Schiebinger directed the European Commission Expert Group to produce Gendered Innovations 2: How Inclusive Analysis Contributes to Research and Innovation. Institutes for Gendered Innovations research opened in Soeul, South Korea, in 2015 and in Tokyo, Japan, in 2022.
Schiebinger’s work has been featured in Science: A Framework for Sex, Gender, and Diversity Analysis in Research: Funding Agencies Have Ample Room to Improve Their Policies (2022); Nature: Sex and Gender Analysis Improves Science and Engineering (2019); Nature: Design AI so that it's Fair (2018); Nature: Accounting for Sex and Gender Makes for Better Science (2020).
Her work in the eighteenth century investigates the circulation of knowledge in the Atlantic World. Her Secret Cures of Slaves: People, Plants, and Medicine in the Eighteenth-Century Atlantic World reconceptualizes research in four areas: first and foremost knowledge of African contributions to early modern science; the historiography of race in science; the history of human experimentation; and the role of science in the eighteenth-century Atlantic world. Her prize-winning Plants and Empire: Colonial Bioprospecting in the Atlantic World investigates women's indigenous knowledge of abortifacients and why this knowledge did not travel.
Londa Schiebinger has been the recipient of numerous prizes and awards, including the prestigious Alexander von Humboldt Research Prize and John Simon Guggenheim Fellowship. She was awarded an honorary doctorate from the Vrije Universiteit Brussel, Belgium (2013), the Faculty of Science, Lund University, Sweden (2017), and the University of Valencia, Spain (2018); the Berlin Falling Walls Breakthrough Winner in Science & Innovation Management (2022). Her work has been translated into numerous languages. In 2022/23, she served as an advisor to the Berlin University Alliance. -
Alain P Schläepfer
Social Science Research Scholar
BioAlain Schläpfer is a Lecturer in Political Science and Economics and the Director of the Data Science track in Political Science. His research examines the evolution of cooperation among individuals and groups, with a particular emphasis on the role of reputational concerns. He also investigates the formation of preferences and of cultural norms, as well as their effects on behavior and long term outcomes. Alain's research has been published in journals in political science, economics and biology, and makes use of formal modelling, causal identification and computer simulations. Originally from Switzerland, Alain received his PhD from Universitat Pompeu Fabra in Barcelona, Spain..
-
David Schneider
Professor of Microbiology and Immunology
On Partial Leave from 03/24/2024 To 10/23/2024Current Research and Scholarly InterestsWe study innate immunity and microbial pathogenesis. We have been studying models for a variety of bacterial infections including: Listeria, Mycobacteria, Salmonella and Streptococcus as well as some fungi, malaria and viruses. Our current focus is to determine how we recover from infections.
-
Mark J. Schnitzer
Professor of Biology, of Applied Physics and of Neurosurgery (Adult Neurosurgery)
Current Research and Scholarly InterestsThe goal of our research is to advance experimental paradigms for understanding normal cognitive and disease processes at the level of neural circuits, with emphasis on learning and memory processes. To advance these paradigms, we invent optical brain imaging techniques, several of which have been widely adopted. Our neuroscience studies combine these imaging innovations with behavioral, electrophysiological, optogenetic and computational methods, enabling a holistic approach to brain science.
-
Dustin Schroeder
Associate Professor of Geophysics, of Electrical Engineering and Senior Fellow at the Woods Institute for the Environment
BioMy research focuses on advancing the scientific and technical foundations of geophysical ice penetrating radar and its use in observing and understanding the interaction of ice and water in the solar system. I am primarily interested in the subglacial and englacial conditions of rapidly changing ice sheets and their contribution to global sea level rise. However, a growing secondary focus of my work is the exploration of icy moons. I am also interested in the development and application of science-optimized geophysical radar systems. I consider myself a radio glaciologist and strive to approach problems from both an earth system science and a radar system engineering perspective. I am actively engaged with the flow of information through each step of the observational science process; from instrument and experiment design, through data processing and analysis, to modeling and inference. This allows me to draw from a multidisciplinary set of tools to test system-scale and process-level hypotheses. For me, this deliberate integration of science and engineering is the most powerful and satisfying way to approach questions in Earth and planetary science.
-
Birgitt Schuele
Associate Professor (Research) of Pathology
BioBirgitt Schüle, MD, is an Associate Professor in the Department of Pathology at Stanford University School of Medicine. Her research focuses on medical genetics and stem cell modeling to uncover disease mechanisms and pathways involved in neurodegeneration in Parkinson's disease and related disorders. She is dedicated to developing novel therapeutic strategies that contribute to the advancement of precision medicine.
Dr. Schüle obtained her medical training from the Georg-August University Göttingen and Medical University Lübeck, Germany, between 1993 and 2001. She earned her doctoral degree in medicine (Dr. med.) in neurophysiology from the Georg-August University Göttingen in 2001. During her neurology internship from 2001 to 2002 at the Medical University of Lübeck under the guidance of Prof. Christine Klein. Subsequently, she pursued a postdoctoral fellowship in human genetics with Prof. Uta Francke at Stanford University School of Medicine from 2003 to 2005.
From 2005 to 2019, Dr. Schüle demonstrated leadership in spearheading critical clinical research programs and establishing essential biospecimen repositories for neurogenetics, translational stem cell research, and brain donation at the Parkinson's Institute and Clinical Center.
Dr. Schüle serves as the Associate Core Leader, Neuropathology, within the Stanford Alzheimer Research Center (ADRC). Her contributions to ADRC include the establishment of Stem Cell Program that supports a human induced pluripotent stem cell and post-mortem leptomeninges tissue bank. These resources are shared with repositories at the National Institutes of Health (NIH), facilitating collaborative research and advancing our understanding of neurodegenerative diseases.
Dr. Schüle's expertise and dedication in the field of neurodegeneration contribute significantly to the advancement of medical knowledge. She is recognized as a respected member of the scientific community, playing an important role in the pursuit of effective treatments and precision medicine approaches.
